Statin use after cancer diagnosis and survival among patients with cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Statin use after cancer diagnosis may improve survival for lung and pancreatic cancer patients. Further clinical trials are needed to confirm these promising findings for cancer survival.
Area Of Science
- Oncology
- Pharmacology
- Epidemiology
Background
- Conflicting evidence exists regarding statin use and cancer survival.
- Previous studies have yielded inconsistent results on the impact of statins on patient outcomes.
Purpose Of The Study
- To investigate the association between statin use after diagnosis and survival in six common cancers.
- Utilized the SEER-Medicare database to analyze cancer survival rates in relation to statin prescription fills.
Main Methods
- Included patients aged 66+ diagnosed with prostate, colorectal, lung, bladder, pancreatic cancer, or non-Hodgkin lymphoma (NHL) between 2008-2017.
- Defined statin use as two or more prescription fills post-diagnosis.
- Employed time-dependent Cox proportional hazard regression models to assess cancer-specific mortality.
Main Results
- Statin use post-diagnosis was linked to a reduced risk of cancer-specific mortality in lung cancer (HR 0.81) and pancreatic cancer (HR 0.72).
- No statistically significant association was found for prostate, colorectal, bladder cancers, or NHL.
- A dose-response relationship was observed for statin duration in lung and pancreatic cancers.
Conclusions
- Statin use following diagnosis shows a potential association with improved survival in lung and pancreatic cancers.
- Clinical trials are recommended to validate these findings and explore statin therapy for these cancer patients.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...